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Abstract
Background. Patients diagnosed with end-stage renal disease experience a significant level of symptom 
burden, including pain, nausea and vomiting, inability to urinate, fatigue etc. At this point in disease 
progression, it is important to establish what types and choices of therapy are most suitable for these 
patients, in particular, the value of continuing dialysis treatment. 
Material and methods. A self-administered questionnaire was distributed among Polish residential hos-
pices and hospital based palliative medicine wards. All responses obtained underwent statistical analysis 
using Pearson’s Chi Square test.
Results. Permanent palliative care facilities, from which 73 out of 166 registered in Poland, took part in 
the survey. ESRD patients were identified to be cared by 81% of the aforementioned institutions. The most 
common treatment approach for these patients was highlighted as conservative treatment (68%), followed 
by hemodialysis (47%), whereas merely 11% provided peritoneal dialysis. Differences between facilities were 
identified relating to therapeutic recommendations for terminal ESRD patients with residential hospices 
more likely to recommend dialysis in conjunction with palliative care, whereas palliative wards advocated 
a withdrawal from dialysis followed by the initiation of palliative care.
Conclusion. All surveyed facilities considered ESRD patients eligible for guaranteed hospice and palliative 
care services. However, certain changes are needed to improve care for ESRD patients, including: the 
development of collaborative partnerships between hospices, dialysis centers and nephrologists, devel-
opment of guidelines for withdrawing dialysis and applying conservative treatment, introducing better 
renal-based training for medical personnel as well as the introduction of transparency within rules relating 
to the financing of these services.
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ded within residential hospices and hospital-based 
palliative medicine wards. Therefore, the purpose of 
this study is to address these gaps in knowledge and 
provide an insight into hospice and palliative care in 
patients with ESRD in Poland. 
Material and methods
A self-administered, anonymous survey was distri-
buted among hospices and palliative care units in 
Poland. This survey was designed on the basis of both 
specialist literature and the authors’ own experience. 
The survey, along with a cover letter, was sent by mail 
to all residential hospices (n = 93) and hospital-based 
palliative medicine wards (n = 73) registered in the Po-
lish Health Care Units Register (total = 166). The survey 
was asked to be completed by a representative of each 
unit and only one survey was completed per facility. 
All data analysis was performed using STATISTICA 
Version 10 software (StatSoft, Inc., 2011). Pearson’s 
Chi-square Test and was used to compare variables 
of interest.
Results
Overall, a total of 73 units participated in the study, 
with a survey response rate of 44%. The responses 
came from representatives of 42 stationary hospices 
and 31 palliative medicine wards.
Units treating esrd patients
It was found that 81% of all units surveyed treated 
patients with ESRD (n = 59), comprising 37 residential 
hospices (88%) and 22 hospital-based palliative medi-
cine wards (71%). No statistically relevant differences 
were observed between the number of units taking 
care of ESRD patients (p = 0.07).
Per annum, more than half of surveyed institutions 
(37) reported that they cared for between 1 and 
5 ESRD patients, 10 units (14%) admitted between 
5 and 10 patients, 5 (7%) treated between 10 and 
20 ESRD patients and 6 (8%) looked after between 
20 and 50. The majority of surveyed units caring for 
ESRD patients did so in collaboration with a dialysis 
center. Alternatively, more than one third of facilities 
acted independently, making use of their own availa-
ble methods and resources (Tab. 1).
Types of treatment 
In terms of the types of therapeutic options of-
fered and provided to ESRD patients in residential 
hospices and palliative wards, it was found that 
conservative management was applied in 68% of 
units, hemodialysis in 47% and only 11% of surveyed 
Introduction
Chronic kidney disease (CKD) is a significant public 
health issue, with a growing incidence, attributed to 
an ageing population as well as an ever-increasing 
number of chronically ill individuals [1]. In Poland, the 
number of patients suffering from CKD has already exce-
eded 10% of the country’s population [2]. As a condition 
associated with a high burden of illness as well as pre-
mature mortality, treatment provided to patients aims to 
provide the most benefit to quality of life [1]. According 
to the Report on Renal Replacement Therapy in Poland, 
in 2011, 21.956 people were provided with renal repla-
cement therapy [3]. As of Dec 31st 2011, 17.963 patients 
had received hemodialysis or peritoneal dialysis (92.4% 
and 7.6%, respectively), whilst 1042 patients under-
went renal transplantation [3, 4]. There is insufficient 
investigation data and research in Poland concerning 
the number of end-stage renal disease (ESRD) patients 
who either did not undergo renal replacement therapy 
or stopped receiving it. In those cases the most common 
form of therapy is conservative treatment. 
As an alternative to dialysis-based therapy, the 
application of the ‘conservative’ approach in ESRD 
patients is gaining more interest [5]. Comprising of 
non-dialytic management of the condition, this form 
of treatment corresponds to palliative care, which 
is often regarded to be the most appropriate care 
setting for ESRD patients [6, 7]. The sole purpose of 
this type of therapy is focused on improving and ma-
intaining patient’s best possible quality of life, rather 
than prolonging a patient’s life at all cost [8]. This is 
achieved through effective, individualized symptoma-
tic treatment, consisting of good pain management, 
and the minimization of other burdensome symptoms, 
as well as providing patients and their families with 
psychosocial and spiritual support [9]. Furthermore, 
careful attention to fluid balance, blood pressure, 
acidosis, anaemia as well as dietary modifications have 
been recognized as important elements of this form 
of therapy [5]. A study by Lichodziejewska-Niemierko 
highlights that palliative care is required not only 
during the final stages of ESRD, but also during the 
period of active treatment, regardless of the type of 
individualized therapy [10]. Despite this fact, currently 
in Poland, the diagnosis of ESRD in an adult does not 
guarantee a patient with palliative and hospice care. 
However, this type of care is possible for children 
diagnosed under the age of eighteen.
In Poland there are no studies exploring the types 
of therapies provided to ESRD patients in hospice 
and palliative care. Furthermore, to our knowledge, 
there are no studies on a worldwide scale that inve-
stigate differences between ESRD patient care provi-
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institutions utilized peritoneal dialysis. However, when 
used, peritoneal dialysis was employed by twice as 
many residential hospices as palliative medicine wards 
(Tab. 2). Nevertheless, in this area no statistically 
relevant discrepancies between residential hospices 
and hospital-based palliative medicine wards were 
observed (p > 0.05). 
Participants were asked for their opinions on the 
types of treatment they believed should be provi-
ded to ESRD patients. Respondents from 63 (86%) 
facilities, made up of 35 residential hospices (83%) 
and 28 palliative medicine wards (90%), expressed 
the need to offer ESRD patients palliative care. Al-
ternatively, 4 (10%) residential hospices and 1 (3%) 
palliative medicine ward disagreed. Opinions on this 
matter differed slightly, depending on the type of 
institution. However, no statistically relevant differen-
ces were observed between residential hospices and 
palliative medicine wards (p = 0.49). Furthermore, 
when questioned about therapy recommendations for 
terminal ESRD patients, palliative care and continuous 
dialysis therapy were the most frequently suggested 
therapeutic approaches, with significant statistical di-
screpancies between residential hospices and palliative 
medicine wards (p = 0.005) (Tab. 3). For non-dialyzed 
ESRD patients, 47 units (64%) advocated the provision 
of palliative care in accompaniment with conservative 
treatment of ESRD, whereas almost one third of re-
spondents suggested the implementation of palliative 
care along with the initiation of dialysis. Regarding 
the former medical strategy, the provision of palliative 
care with only conservative treatment was observed 
more often in hospital-based palliative medicine wards 
than in residential hospices (p = 0.04) (Tab. 4).
Table 1. Cooperation between nephrologists and residential hospices/palliative medicine wards offering tre-
atment to ESRD patients
While taking care of patients  








collaborated with a dialysis center 27 (64%) 13 (42%) 40 (55%)
acted independently, making use of available 
methods and resources
14 (33%) 12 (39%) 26 (36%)
consulted patient’s case with a nephrologist 15 (36%) 8 (26%) 23 (32%)
collaborated with a hospital nephrology ward 11 (26%) 7 (23%) 18 (25%)
no response 5 (12%) 9 (29%) 14 (19%)
Table 2. Treatment options for patients with ESRD in inpatient palliative care facilities







conservative management 30 (71%) 20 (65%) 50 (68%)
hemodialysis 20 (48%) 14 (45%) 34 (47%)
peritoneal dialysis 6 (14%) 2 (7%) 8 (11%)
no response 6 (14%) 9 (29%) 15 (20%)
Table 3. Medical strategies towards dialysis patients in terminal state recommended by the respondents







providing the patient with palliative care 
and continuous dialysis 
39 (93%) 21 (68%) 60 (82%)
withdrawal from dialysis and initiation of 
palliative care
1 (2%) 9 (29%) 10 (14%)
continuing dialysis without providing 
palliative care
2 (5%) 1 (3%) 3 (4%)
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Table 4. Medical strategies towards non-dialyzed ESRD patients in terminal state recommended  
by the respondents







providing the patient with palliative care ac-
companied by conservative treatment
23 (55%) 24 (78%) 47 (64%)
providing the patient with palliative care 
along with initiation of dialysis
17 (40%) 6 (19%) 23 (32%)
conservative treatment without providing the 
patient with palliative care 
2 (5%) 1 (3%) 3 (4%)
initiation of dialysis at a nephrological care 
facility without providing the patient with 
palliative care
0 (0%) 0 (0%) 0 (0%)
Table 5. Expectations of ESRD patients and their families at residential hospices and hospital-based palliative 
medicine wards towards medical strategies 
Expectations of patients  









patients families patients families patients families
continuing dialysis and other medi-
cal actions aiming at life prolonga-
tion until the end of life
24 (57%) 31 (74%) 12 (39%) 20 (64%) 36 (49%) 51 (70%)
withdrawal from dialysis and 
focusing instead on pain alleviating 
measures along with combating 
other burdensome symptoms
13 (31%) 7 (17%) 11 (35%) 3 (10%) 24 (33%) 10 (14%)
no response 5 (12%) 4 (9%) 8 (26%) 8 (26%) 13 (18%) 12 (16%)
Patient expectations of care
Nearly half of respondents highlighted that ESRD 
patients expected dialysis therapy and other medical 
actions aimed at the prolongation of life to be conti-
nued until the end of life, and 70% maintained that 
patients families also expected this approach to be 
undertaken. Respondents identified that in their expe-
rience, 33% of patients and 14% of patient families 
preferred to undertake a conservative form of therapy, 
comprising withdrawal from dialysis and symptomatic 
treatment i.e. pain alleviating measures and minimi-
zation of other burdensome symptoms. There were 
major statistical differences (p = 0.00000) found when 
comparing opinions on the expectations of ESRD pa-
tients and those of their families (Tab. 5). 
Specialised nephrology training  
for medical personnel
Overall, it is apparent that the performance of 
specialized nephrological training for health care 
professionals in these care settings was not highly 
implemented. Physicians were more likely to hold 
nephrological training than other health care pro-
fessionals, with 13 of the 73 (18%) surveyed units 
employing physicians holding a completed course 
or training in hemodialysis and 11 of 73 (15%) in 
peritoneal dialysis. There were even less specially tra-
ined nurses, with only 7% and 6% (n = 5.4) of units 
respectively employing nurses with qualifications in 
hemodialysis and peritoneal dialysis.
However, nearly 90% of respondents acknowled-
ged a need for the provision of training for medical 
personnel in residential hospices and palliative me-
dicine wards on nephrology-based topics. Answers 
in the affirmative consisting of ‘yes’ and ‘rather yes’ 
were provided by 34 (47%) and 31 (42%) respondents 
respectively, whereas 2 (3%) decided that there was 
no need for training, and further 4 (6%) highlighted 
that they did not want such courses.
Barriers and changes needed to improve care
The most frequently mentioned barrier to pro-
viding care to ESRD patients in Polish residential 
hospices or palliative medicine wards related to the 
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settling of financial costs of such care with the Na-
tional Health Fund, followed by a lack of specialized 
knowledge related to the care of ESRD patients and 
a lack of specialized equipment (Tab. 6). 
When considering changes needed to improve 
care provided to ESRD patients, the most urgently 
perceived need related to the development and im-
plementation of a collaborative partnership between 
institutions and hospices specializing in caring for 
ESRD patients (71% of all facilities). Additionally, 
68% of respondents highlighted a need for greater 
transparency amongst regulations set by the National 
Health Fund, specifically those that govern the finan-
cing of services. Another recommendation indicated 
by 66% of units emphasized the need for organized 
professional training for personnel or the broadening 
of current palliative medicine programs to include 
topics related to the treatment of ESRD patients. Fur-
thermore, 44% of units proposed the organisation of 
information campaigns for nephrological patients and 
their families relating to the possibility of receiving 
hospice and palliative care services. 
Discussion
To our knowledge, this is the first form of scientific 
research that has been dedicated to exploring the type 
of hospice and palliative care provided to ESRD pa-
tients in Poland. Furthermore, this is the first national 
survey to take into account discrepancies occurring 
between residential hospices and palliative medicine 
wards. However, the obtained results do not concern 
all existing units, therefore they should be interpreted 
with caution. Naturally, there are pre-existing signifi-
cant differences between hospices and palliative care 
wards, particularly when considering their organiza-
tional structure. Hospices are generally independent 
health care institutions, whilst the latter are hospital 
wards. Nevertheless, the scope and conditions of care 
services provided to patients are comparable across 
both types of facilities.
The study has demonstrated that the majority of 
Polish hospice and palliative care facilities recognize 
a need to provide care to ESRD patients. This is an im-
portant finding, as currently in Poland, the diagnosis 
of end-stage renal disease does not constitute suffi-
cient basis for providing adult patients with hospice 
and palliative care. This study has highlighted that 
despite this, the facilities surveyed do in fact provide 
care to ESRD patients, albeit a small number. It is no-
ted ,however, that the admittance of these patients 
to a residential hospice or palliative medicine ward 
depends on the co-occurrence of a disease (co-morbi-
dity), which then entitles a patient to care. One such 
comorbidity is cancer, which in 2010 was responsible 
for 6.6% of deaths among dialysis patients in Poland 
[3]. All ESRD patients who died of cancer were enti-
tled hospice and palliative care services during the 
final stages of their lives. Therefore, palliative care 
in Poland, unlike in Great Britain, is only available to 
ESRD patients under certain circumstances and not 
in conjunction with renal replacement therapy [11]. 
However, ESRD patients cared for at inpatient hospice 
and palliative care facilities who qualify for dialysis are 
eligible for publically-financed hemodialysis and peri-
toneal dialysis services provided by dialysis centers. In 
comparison, in the United Kingdom, once a patient 
is diagnosed with ESRD, they are able to be admitted 
to a hospice and are offered palliative care. Alter-
natively, ESRD patients treated within a hospital are 
Table 6. Major obstacles related with providing care to ESRD patients by residential hospices or palliative 
medicine wards









difficulties related with settling the financial 
costs with the National Health Fund
21(50%) 22 (71%) 43 (59%)
lack of specialist knowledge and/or qualifica-
tions of the facility’s personnel
15 (36%) 12 (39%) 27 (37%)
lack of specialist equipment 15 (36%) 9 (29%) 24 (33%)
insufficient support from nephrologists, dialy-
sis centers or hospital nephrology wards
7 (17%) 7 (23%) 14 (19%)
personnel’s unwillingness to treat and nurse 
ESRD patients 
2 (5%) 0 (0%) 2 (3%)
other 10 (24%) 7 (23%) 17 (23%)
no response 2 (5%) 2 (7%) 4 (6%)
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entitled to specialist services provided by a palliative 
care team [12]. Although in Poland these supporting 
teams are mentioned in legal regulations, with rare 
exceptions they are largely non-existent due to the 
lack of financing from the National Health Fund [13, 
14]. This provides reasoning for the limited number of 
ESRD patients cared for by the surveyed institutions.
The findings of the study also identified a high 
ratio of conservative treatment compared to renal re-
placement therapy performed for ESRD patients. This 
indicates that for the majority of ESRD patients admit-
ted to inpatient hospice and palliative care facilities, 
dialysis therapy was either never initiated or was termi-
nated. As such, these results justify the establishment 
of reliable standards to guide conservative treatment 
provided to ESRD patients nearing the end of life, as 
suggested by Murtagh and her colleagues [15]. Inte-
restingly, there was a discrepancy among the therapy 
recommendations suggested by residential hospices 
and palliative medicine wards. The most frequently 
recommended medical strategy in residential hospices 
for terminal dialysis patients, was the provision of 
palliative care in conjunction with continuous dialysis 
therapy. Alternatively, nearly one third of respondents 
from palliative medicine wards advocated the withdra-
wal from dialysis followed by the initiation of palliative 
care. Furthermore, respondents revealed that patients 
at residential hospices are much more likely to expect 
continuing dialysis and other life prolongation medical 
activities than those cared for at palliative medicine 
wards. Therefore, a conclusion can be drawn that 
dialysis is applied far more frequently at residential 
hospices than at palliative medicine wards. 
The high percentage of participants who suppor-
ted the continuation of dialysis in terminal patients 
may be attributed to the lack of specific guidelines 
related to the withdrawal of renal replacement the-
rapy in Poland [16]. Doctors’ unwillingness to ter-
minate previously initiated dialysis therapy can also 
stem from the fact that there are no clear legal rules 
pertaining to this issue. It is worth mentioning that 
in accordance with the current law, a physician has 
no right to initiate renal replacement therapy without 
the patient’s consent or in the face of the patient’s 
strong opposition to this form of care. In cases where 
dialysis has already been introduced, only the patient’s 
own objection to this therapy may exempt the phy-
sician from continuing. In all remaining cases — for 
example when a patient is unconscious or unable to 
express objection due to other causes — terminating 
renal replacement therapy entails the risk of rende-
ring the physician liable to prosecution. In light of 
the above reasons, withdrawal from dialysis is not 
usually part of the medical strategy recommended to 
ESRD patients in a terminal state, although this option 
should also be made available to them [17]. Despite 
the abovementioned difficulties and expectations, 
the decision to reject or withdraw dialysis therapy in 
palliative ESRD patients is a commonplace practice, as 
evidenced by the scale of conservative treatment use. 
The patient’s right to withdraw from renal repla-
cement therapy or to reject it altogether is observed 
in France, Canada, the United States and the United 
Kingdom, where the legal situation is not as complica-
ted as it is in Poland. In the United States and France, 
withdrawal from dialysis is the cause of one in five 
deaths of dialysis patients, and is experienced by both 
nephrologists and general practitioners [18, 19]. In 
the United Kingdom the law draws attention to the 
patient’s right to choose between continuing or with-
drawing from dialysis therapy, while simultaneously of-
fering support in the form of hospice and palliative care 
to both the patients and their families [20]. In Canada 
almost one fifth of deaths among patients receiving 
dialysis are caused by withdrawal from dialysis, and 
the decision to discontinue renal replacement therapy 
is most often determined by the patient’s psychosocial 
condition or the development of cancer [21].
When considering any differences between hospi-
ces and palliative wards, it was found that patients 
in residential hospices underwent dialysis more often 
than those in palliative medicine wards. This can be 
attributed to the fact that the location of the palliative 
unit within the hospital structure was not necessarily 
conducive to the running of hemodialysis, due to the 
hospital running their own dialysis centers in a se-
parate wing. The need to transport a patient from 
a hospice to an institution providing renal replacement 
therapy, (which can be an additional burden for the 
patient), was not seen to negatively affect the level of 
dialysis performance in residential hospices in compa-
rison to palliative medicine wards. There is a similar 
relationship observed between the type and scope of 
collaboration between the surveyed institutions and 
nephrology units. Residential hospices were found to 
work in partnership with dialysis centers and nephro-
logists more frequently than palliative medicine wards, 
which typically operated independently. This need for 
a teamwork approach between palliative and nephro-
logical care facilities is supported by a study conducted 
by Hobson et al. in the United Kingdom [12].
Participants described the types of barriers present 
in the current Polish system that limited care to ESRD 
patients. The most commonly reported issue related 
to the difficulties experienced with settling financial 
costs attributed to care with the National Health 
Fund. Other barriers identified included the lack of 
specialist renal knowledge and qualifications of per-
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sonnel working in these facilities, as well as the lack of 
support from nephrological care institutions. Despite 
these barriers, inpatient hospice and palliative care 
institutions have demonstrated that they are ready 
to provide their services to ESRD patients. It is appa-
rent, however that this could only become a reality 
subsequent to the introduction of legislative changes 
surrounding patient eligibility for hospice and palliati-
ve care services and the financing of this type of care 
from public resources.
The study has also identified the need for several 
changes to be implemented to improve the care of 
ESRD patients. Participants requested the develop-
ment and establishment of a collaborative partnership 
between institutions specializing in treating ESRD 
patients and hospice and palliative care units (repre-
sentatives of palliative medicine wards employees ack-
nowledged this to a lesser degree than their residential 
hospice counterparts). Additionally, the introduction 
of greater transparency within the regulations set by 
the National Health Fund governing the financing of 
health services was commonly highlighted by partici-
pants — this was stressed more strongly by palliative 
medicine wards than by residential hospices. Both 
surveyed groups also equally supported the idea of 
organizing professional training sessions for medical 
personnel, and broadening the existing palliative 
medicine courses to include topics related to the 
treatment of ESRD patients. 
This research has shown that the majority of the 
surveyed medical managers of wards in palliative care 
institutions, who are usually doctors by profession, 
advocate the provision of continuous dialysis to ter-
minal patients. This perspective seems to oppose the 
principles of palliative care. When considering a ter-
minal ESRD patient in a palliative care institution with 
significant symptom burden, the validity of continuing 
dialysis must be taken into account. The foremost 
concern when caring for ESRD patients, should be 
to improve and maintain the best possible quality of 
life [5]. Persisting with medical strategies aimed at 
prolonging life, violate the patients right to a peaceful 
and dignified death. As such, any therapeutic recom-
mendations should seek to uphold this principle and 
promote an appropriate level of patient care. 
Conclusions
The majority of surveyed facilities recognized the 
need to provide ESRD patients with guaranteed hospi-
ce and palliative care services. Current legislation and 
legal regulations that govern the financing of health 
care services in Poland were considered to be a major 
barrier to the provision of appropriate palliative care 
to terminal ESRD patients. Therefore, it is essential 
to introduce changes within the law to improve the 
financing health services from the public sector. Re-
spondents also identified other changes needed to 
improve care for ESRD patients including: the need 
for implementing a collaborative partnership between 
hospices, dialysis centers and nephrologists, as well 
as the provision of specialist renal-based training of 
medical personnel. Furthermore, it was recognized 
that there is a need to establish standards or medical 
practice relating to withdrawal from dialysis and im-
plement a conservative treatment. Further investiga-
tion is needed to develop appropriate care guidelines 
for ESRD patients and to promote the provision of ap-
propriate palliative care services to this patient group. 
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